This study is in progress, not accepting new patients
A Study of Teclistamab With Other Anticancer Therapies in Participants With Multiple Myeloma
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedestimated completion
- Principal Investigator
- by Sandy Wong
Description
Summary
Official Title
Keywords
Eligibility
Locations
Lead Scientist at UCSF
- Sandy Wong
Dr. Sandy Wong is a blood disease specialist who cares for people with MGUS (monoclonal gammopathy of undetermined significance), smoldering myeloma, multiple myeloma and amyloidosis, a condition in which an abnormal protein called amyloid builds up in the body. Wong has a special interest in amyloidosis patients, and her research focuses on that disease.
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Janssen Research & Development, LLC
- ID
- NCT04722146
- Phase
- Phase 1 Multiple Myeloma Research Study
- Study Type
- Interventional
- Participants
- About 140 people participating
- Last Updated